Safety and immunogenicity of DTaP5-IPV compared with DTaP5 plus IPV as the fifth dose in children 4–6 years of age

MJ Smith, E Jordanov, X Sheng… - The Pediatric Infectious …, 2017 - journals.lww.com
Background: Immunogenicity and safety of stand-alone diphtheria, tetanus toxoid, 5-
component acellular pertussis vaccine adsorbed, inactivated poliovirus (IPV) combination …

Safety and Immunogenicity of DTaP5-IPV Compared With DTaP5 Plus IPV as the Fifth Dose in Children 4–6 Years of Age

MJ Smith, E Jordanov, X Sheng… - The Pediatric Infectious …, 2017 - ingentaconnect.com
Background: Immunogenicity and safety of stand-alone diphtheria, tetanus toxoid, 5-
component acellular pertussis vaccine adsorbed, inactivated poliovirus (IPV) combination …

Safety and Immunogenicity of DTaP5-IPV Compared With DTaP5 Plus IPV as the Fifth Dose in Children 4-6 Years of Age.

MJ Smith, E Jordanov, X Sheng… - The Pediatric Infectious …, 2017 - europepmc.org
Background Immunogenicity and safety of stand-alone diphtheria, tetanus toxoid, 5-
component acellular pertussis vaccine adsorbed, inactivated poliovirus (IPV) combination …

Safety and Immunogenicity of DTaP5-IPV Compared With DTaP5 Plus IPV as the Fifth Dose in Children 4-6 Years of Age

MJ Smith, E Jordanov, X Sheng… - The Pediatric …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Immunogenicity and safety of stand-alone diphtheria, tetanus toxoid, 5-
component acellular pertussis vaccine adsorbed, inactivated poliovirus (IPV) combination …

Safety and immunogenicity of DTaP5-IPV compared with DTaP5 plus IPV as the fifth dose in children 46 years of age.

MJ Smith, E Jordanov, SXH Sheng XiaoHua, PH Tsang - 2017 - cabidigitallibrary.org
Background: Immunogenicity and safety of stand-alone diphtheria, tetanus toxoid, 5-
component acellular pertussis vaccine adsorbed, inactivated poliovirus (IPV) combination …